Founded in Switzerland in 2001, Eclosion SA invests in startups primarily in Europe, with a focus on companies that are 6-10 years old. The firm typically invests in rounds with 1-2 participants and has been involved in funding rounds alongside Vesalius Biocapital Partners, MP Healthcare Venture Management, and Andera Partners. Some of their notable portfolio startups include Genkyotex and Calypso Biotech. Eclosion SA has a higher rate of exits compared to other organizations and is known for deals ranging from $10-50 million. Their main activity was in 2013, and they are involved in less than 2 deals per year.